TP53 and colon adenocarcinoma: Antiproliferative activity of Phase I metabolites of SLMP53-1 (6) in human colon adenocarcinoma HCT116 cells expressing p53 (HCT116 p53+/+) and HCT116 cells with p53 expression knocked out (HCT116 p53−/−).